Inactive Instrument

Other languages Cytori Therapeutics Inc Deutsche Boerse AG

Equities

US23283K1051

End-of-day quote Deutsche Boerse AG Other stock markets
- ^EUR	-

Jun. 07	Plus Therapeutics, Inc. Receives the Resignation of Dr. Norman Lafrance, Its Chief Medical Officer, Effective June 12, 2024	CI
Jun. 07	Plus Therapeutics to Receive $3.3 Million Advance Payment From CPRIT For Radiotherapeutic Development Program	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Plus Therapeutics, Inc. Receives the Resignation of Dr. Norman Lafrance, Its Chief Medical Officer, Effective June 12, 2024	Jun. 07
Plus Therapeutics to Receive $3.3 Million Advance Payment From CPRIT For Radiotherapeutic Development Program	Jun. 07
Plus Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Plus Therapeutics, Inc. acquired CNSide, a leptomeningeal metastases diagnostic platform.	May. 08
Plus Therapeutics, Inc. Announces Validation & Clinical Implementation of Csf-01 Leptomeningeal Cancer Cell Diagnostic	Mar. 25
Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium Obisbemeda in Leptomeningeal Metastases	Mar. 11
Plus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05
Plus Therapeutics, Inc. Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting	Nov. 20
Top Premarket Gainers	Nov. 03
Plus Therapeutics, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 and Calendar Year of 2024	23-10-31
Plus Therapeutics, Inc. announces an Equity Buyback for $0.5 million worth of its shares.	23-10-31
Plus Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31
Plus Therapeutics, Inc. authorizes a Buyback Plan.	23-10-30
Plus Therapeutics, Inc. Completes Dosing in Cohort 4 of ReSPECT-LM Phase 1 Clinical Trial of Rhenium Obisbemeda in Leptomeningeal Metastases	23-10-10
Sector Update: Health Care Stocks Slipping Late Friday8 Afternoon	23-09-08
Sector Update: Health Care Stocks Slipping Friday Afternoon	23-09-08
Sector Update: Health Care	23-09-08
Biocept Signs Non-Exclusive Licensing Agreement With Plus Therapeutics on CNSide Tumor Cell Platform	23-09-08
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike	23-09-08
Top Premarket Gainers	23-09-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cytori Therapeutics Inc Deutsche Boerse AG

Equities

US23283K1051

Other languages

Filters